AI Hallucination Research › Regulators › Major advanced economies › US › FDA › 21-CFR-111-DIETARY-SUPPLEMENTS-CGMP

21 CFR Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements

Food and Drug Administration (FDA) · published 2007-06-25
Research Pending Awaiting research outcome
Hallucination Shape
(0 Response Hallucination + 0 Citation Hallucination = 0 Hallucination findings)

Response Hallucination Modes (0 failures)

Misstated Rule 0 Outdated 0 Misattributed 0 Inference Drift 0

Citation Hallucination Modes (0 failures)

Fabricated 0
Pretextual 0
Contradictory 0
Hover any mode chip for definition · methodology

Hallucination findings

No published hallucination findings yet for this regulation. Research is queued or in progress.
← All regulations for FDA